The Utrecht Region proudly welcomes Instant NanoBiosensors B.V. to its vibrant landscape of innovation. This heralds a significant milestone for the region, as it embraces an innovative diagnostic technology company poised to transform the landscape of Alzheimer's disease and related #neurodegenerative conditions diagnostics.https://doingbusiness.utrechtregion.com/nieuws/instant-nanobiosensors-b-v-revolutionizes-alzheimers-diagnosis/
It is a great honor for us to be reported by California Life Sciences (CLS) Bulletin MedTech Spotlight as one of 13 companies including Abbot, Johnson & Johnson and so on. This special edition explores medtech innovation, achievement and business operations. Our latest article is named as "How Instant NanoBiosensors Hopes Their Technology Will Lead to Early Diagnosis of Neurological Diseases.” This will also help you understand how the integration of nanotechnology into biosensors could benefit the world by moving bioanalysis from laboratory to analysis point of use.Read the full article: https://www.califesciences.org/cls-bulletin-medtech-spotlight/?utm_campaign=CLS%20Bulletin&utm_content=200734068&utm_medium=social&utm_source=linkedin&hss_channel=lcp-100195
Many thanks to EETimes Asia for the invitation. The article was released today with the title “A new method to advance in the early detection of Alzheimer's disease". In this article, Tony Chung, CEO of Instant NanoBiosenosors, presented how INB’s technology can light up the hope for early detection of Alzheimer’s disease in a promising way.Read the full article: https://www.eetasia.com/a-new-method-to-advance-the-early-detection-of-alzheimers-disease/
INB will be holding a webinar with our Japanese distributor BM Equipment Co., Ltd to talk about epitope binning with FOPPR™. Join us!Epitope binning immunoassays using Fiber Optic Particle Plasmon Resonance (FOPPR™) technology could be deployed in the development of new potential drug candidates. Furthermore, it could accommodate up to four mAbs in one experiment run, enabling this characterization process to be more time- and material-efficient for scientists.This webinar will discusses how FOPPR™ is used to characterize closely related “bins” of mAbs targeting the same epitope of the target protein and how the selection process is used to develop assays. We also are pleased to take AnTaimmuBioMed as a real-world example to share how they use FOPPR™ to develop COVID-19 related therapeutic antibodies and diagnostic tools.Speakers:Tony Chung (CEO @Instant NanoBiosensors)Aileen Sun (Technical Application Scientist @Instant NanoBiosensors)Topic: Epitope Binning: A Critical Step in Antibody DevelopmentDate: 16th Feb. 2022Time: 10:00am JST (GMT+09)Contact mail: hama@bmbio.co.jp, bd@instantnano.comRegister: https://us02web.zoom.us/webinar/register/WN_9wVT3TkUSIC9wjuEeeJH7Q
INB will be part of many conferences, webinars, and workshops in 2022. Join us!